Sample size determination in fixed-dose combination drug studies

被引：4
|
作者：
Sidik, K
Jonkman, JN
机构：
[1] Wyeth Res, Biometr Res, Princeton, NJ 08543 USA
[2] Mississippi State Univ, Dept Math & Stat, Mississippi State, MS 39762 USA
来源：
PHARMACEUTICAL STATISTICS | 2003年 / 2卷 / 04期
关键词：
binary response; combination drug; intersection-union test; min test;
D O I：
10.1002/pst.67
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In this paper, the application of the intersection-union test method in fixed-dose combination drug studies is discussed. An approximate sample size formula for the problem of testing the efficacy of a combination drug using intersection-union tests is proposed. The sample sizes obtained from the formula are found to be reasonably accurate in terms of attaining the target power 1 - beta for a specified beta. Copyright (C) 2003 John Wiley Sons Ltd.
引用
收藏
页码：273 / 278
页数：6
相关论文
共 50 条
  • [31] Drug-drug interaction profile of sofosbuvir/velpatasvir/voxilaprevir fixed-dose combination
    Garrison, K. L.
    Kirby, B.
    Stamm, L. M.
    Ma, G.
    Vu, A.
    Ling, J.
    Mathias, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S492 - S493
  • [32] Drug-Drug Interaction Profile Of The Fixed-Dose Combination Tablet Ledipasvir/Sofosbuvir
    German, Polina
    Pang, Phillip S.
    Fang, Liang
    Chung, Diana
    Mathias, Anita
    HEPATOLOGY, 2014, 60 : 1162A - 1162A
  • [33] Preparation and in vitro studies of fixed-dose tablet combination of repaglinide and metformin
    Sahin, Sinem
    Mesut, Burcu
    Durgun, M. Ezgi
    Ozcelik, Esher
    Ozsoy, Yildiz
    ISTANBUL JOURNAL OF PHARMACY, 2021, 51 (01): : 26 - 34
  • [34] The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives
    Sanz, Gines
    Fuster, Valentin
    Guzman, Luis
    Guglietta, Antonio
    Albert Arnaiz, Joan
    Martinez, Felipe
    Sarria, Antonio
    Carla Roncaglioni, Maria
    Taubert, Kathryn
    AMERICAN HEART JOURNAL, 2011, 162 (05) : 811 - 817.e1
  • [35] A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
    Sarkar, Manuj K.
    Dey, Subhra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [36] Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation
    Milan-Segovia, R. C.
    Dominguez-Ramirez, A. M.
    Jung-Cook, H.
    Magana-Aquino, M.
    Romero-Mendez, M. C.
    Medellin-Garibay, S. E.
    Vigna-Perez, M.
    Romano-Moreno, S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (11) : 1454 - 1460
  • [37] Fixed-dose combination versus separate drug formula for pulmonary and extrapulmonary tuberculosis
    Maha M. El-Kholy
    Samiaa H. Sadek
    Osama Mahran
    Egyptian Journal of Bronchology, 2018, 12 (3) : 346 - 351
  • [38] Rational approaches to the treatment of hypertension: drug therapy-monotherapy, combination, or fixed-dose combination?
    Canbakan, Basol
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (04) : 349 - 351
  • [39] Determination of metformin in fixed-dose combination tablets by ATR-FTIR spectroscopy
    Sabbagh, B. A.
    Kumar, P. V.
    Chew, Y. L.
    Chin, J. H.
    Akowuah, G. A.
    CHEMICAL DATA COLLECTIONS, 2022, 39
  • [40] History of fixed-dose combination therapy for hypertension
    Wofford, JL
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (09) : 1044 - 1044
12345